Vaccination of an adolescent group with A (H3N2) + A(HSW1N1) bivaccine before an A (H1N1) influenza epidemic.Acta Virol. 1979 Sep; 23(5):443-5.AV
Abstract
A group of 35 adolescents aged 18--22 years were vaccinated intradermally with 0.2 ml of a mixed A (H3N2) + A (Hsw1N1) formolized vaccine and revaccinated with A (Hsw1N1) monovaccine 10 days before an A (H1N1) influenza epidemic. The vaccination had no effect on morbidity or the clinical course of disease. Serology revealed a primary immune response to A (Hsw1N1) and a booster response to A (H3N2). Apparently, prevention of a new influenza subtype by formolized vaccine possessing only the corresponding neuraminidase type is ineffective.
MeSH
Pub Type(s)
Journal Article
Language
eng
PubMed ID
42307
Citation
Stumpa, A, et al. "Vaccination of an Adolescent Group With a (H3N2) + A(HSW1N1) Bivaccine Before an a (H1N1) Influenza Epidemic." Acta Virologica, vol. 23, no. 5, 1979, pp. 443-5.
Stumpa A, Cihla F, Tůmová B, et al. Vaccination of an adolescent group with A (H3N2) + A(HSW1N1) bivaccine before an A (H1N1) influenza epidemic. Acta Virol. 1979;23(5):443-5.
Stumpa, A., Cihla, F., Tůmová, B., Husek, V., & Slezácek, J. (1979). Vaccination of an adolescent group with A (H3N2) + A(HSW1N1) bivaccine before an A (H1N1) influenza epidemic. Acta Virologica, 23(5), 443-5.
Stumpa A, et al. Vaccination of an Adolescent Group With a (H3N2) + A(HSW1N1) Bivaccine Before an a (H1N1) Influenza Epidemic. Acta Virol. 1979;23(5):443-5. PubMed PMID: 42307.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - Vaccination of an adolescent group with A (H3N2) + A(HSW1N1) bivaccine before an A (H1N1) influenza epidemic.
AU - Stumpa,A,
AU - Cihla,F,
AU - Tůmová,B,
AU - Husek,V,
AU - Slezácek,J,
PY - 1979/9/1/pubmed
PY - 1979/9/1/medline
PY - 1979/9/1/entrez
SP - 443
EP - 5
JF - Acta virologica
JO - Acta Virol
VL - 23
IS - 5
N2 - A group of 35 adolescents aged 18--22 years were vaccinated intradermally with 0.2 ml of a mixed A (H3N2) + A (Hsw1N1) formolized vaccine and revaccinated with A (Hsw1N1) monovaccine 10 days before an A (H1N1) influenza epidemic. The vaccination had no effect on morbidity or the clinical course of disease. Serology revealed a primary immune response to A (Hsw1N1) and a booster response to A (H3N2). Apparently, prevention of a new influenza subtype by formolized vaccine possessing only the corresponding neuraminidase type is ineffective.
SN - 0001-723X
UR - https://www.unboundmedicine.com/medline/citation/42307/Vaccination_of_an_adolescent_group_with_A__H3N2__+_A_HSW1N1__bivaccine_before_an_A__H1N1__influenza_epidemic_
L2 - https://medlineplus.gov/flu.html
DB - PRIME
DP - Unbound Medicine
ER -